Epidermal growth factor improved alcohol-induced inflammation in rats

Alcohol

Volumn 48, Issue 7, 2014, Pages 701-706

  Chen, Ya Ling ^a   Peng, Hsiang Chi ^a   Hsieh, Yi Ching ^a   Yang, Suh Ching ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Alcoholic liver disease; Epidermal growth factor; Intestinal integrity; Rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; RECOMBINANT EPIDERMAL GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; ALCOHOL; EPIDERMAL GROWTH FACTOR;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ESCHERICHIA COLI; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; RAT; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; INFLAMMATION; INTESTINE; LIVER; METABOLISM; MICROBIOLOGY; MICROFLORA; WISTAR RAT;

RATTUS;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; EPIDERMAL GROWTH FACTOR; ETHANOL; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTESTINES; LIVER; MALE; MICROBIOTA; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908030659     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2014.07.008     Document Type: Article

References (31)

1. Bode C., Bode J.C. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?. Alcohol: Clinical and Experimental Research 2005, 29:166S-171S.
2. Bulut K., Felderbauer P., Hoeck K., Schmidt W.E., Hoffmann P. Increased duodenal expression of transforming growth factor-alpha and epidermal growth factor during experimental colitis in rats. European Journal of Gastroenterology & Hepatology 2008, 20:989-994. http://www.ncbi.nlm.nih.gov/pubmed?term=increased%20duodenal%20epxression%20of%20%2C%202008%2C%2020%2C%20989-#.
3. Chen Y.L., Yang S.S., Peng H.C., Hsieh Y.C., Chen J.R., Yang S.C. Folate and vitamin B12 improved alcohol-induced hyperhomocysteinemia in rats. Nutrition 2011, 27:1034-1039.
4. Clark J.A., Clark A.T., Hotchkiss R.S., Buchman T.G., Coopersmith C.M. Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis. Shock 2008, 30:36-42.
5. Criado-Jiménez M., Rivas-Cabañero L., Martín-Oterino J.A., López-Novoa J.M., Sánchez-Rodríguez A. Nitric oxide production by mononuclear leukocytes in alcoholic cirrhosis. Journal of Molecular Medicine 1995, 73:31-33.
6. Dvorak B., Halpern M.D., Holubec H., Williams C.S., McWilliam D.L., Dominguez J.A., et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. American Journal of Physiology. Gastrointestinal and Liver Physiology 2002, 282:G156-G164. http://www.ncbi.nlm.nih.gov/pubmed?term=epidermal%20growth%20factor%2C%202001%2C%20282%2C%20G156.
7. Farhadi A., Keshavarzian A., Fields J.Z., Sheikh M., Banan A. Resolution of common dietary sugars from probe sugars for test of intestinal permeability using capillary column gas chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2006, 836:63-68.
8. Farhadi A., Keshavarzian A., Holmes E.W., Fields J., Zhang L., Banan A. Gas chromatographic method for detection of urinary sucralose: application to the assessment of intestinal permeability. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2003, 784:145-154.
9. Gramenzi A., Caputo F., Biselli M., Kuria F., Loggi E., Andreone P., et al. Review article: alcoholic liver disease-pathophysiological aspects and risk factors. Alimentary Pharmacology & Therapeutics 2006, 24:1151-1161.
10. Heitz P.U., Kasper M., van Noorden S., Polak J.M., Gregory H., Pearse A.G. Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands. Gut 1978, 19:408-413.
11. Hézode C., Lonjon I., Roudot-Thoraval F., Pawlotsky J.M., Zafrani E.S., Dhumeaux D. Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study. Alimentary Pharmacology & Therapeutics 2003, 17:1031-1037.
12. Hill D.B., D'Souza N.B., Lee E.Y., Burikhanov R., Deaciuc I.V., de Villiers W.J. Arole for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol: Clinical and Experimental Research 2002, 26:74-82. http://www.ncbi.nlm.nih.gov/pubmed?term=aa%20role%20for%20interleukin10%2C%202002%2C%2026%2C%2074-#.
13. Hoek J.B., Pastorino J.G. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002, 27:63-68.
14. Hunt N.C., Goldin R.D. Nitric oxide production by monocytes in alcoholic liver disease. Journal of Hepatology 1992, 14:146-150.
15. Ishikawa S., Cepinskas G., Specian R.D., Itoh M., Kvietys P.R. Epidermal growth factor attenuates jejunal mucosal injury induced by oleic acid: role of mucus. The American Journal of Physiology 1994, 267:G1067-G1077.
16. Itoh M., Matsuo Y. Gastric ulcer treatment with intravenous human epidermal growth factor: a double-blind controlled clinical study. Journal of Gastroenterology and Hepatology 1994, 9:S78-S83.
17. Järveläinen H.A., Fang C., Ingelman-Sundberg M., Lindros K.O. Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines. Hepatology 1999, 29:1503-1510.
18. Kasselberg A.G., Orth D.N., Gray M.E., Stahlman M.T. Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues. The Journal of Histochemistry and Cytochemistry 1985, 33:315-322.
19. Keshavarzian A., Holmes E.W., Patel M., Iber F., Fields J.Z., Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. The American Journal of Gastroenterology 1999, 94:200-207.
20. Kirpich I.A., Solovieva N.V., Leikhter S.N., Shidakova N.A., Lebedeva O.V., Sidorov P.I., et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 2008, 42:675-682.
21. Lieber C.S., DeCarli L.M. Animal models of chronic ethanol toxicity. Methods in Enzymology 1994, 233:585-594.
22. Marti U., Burwen S.J., Jones A.L. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology 1989, 9:126-138.
23. McClain C.J., Barve S., Deaciuc I., Kugelmas M., Hill D. Cytokines in alcoholic liver disease. Seminars in Liver Disease 1999, 19:205-219.
24. McClain C.J., Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989, 9:349-351.
25. Pikaar N.A., Wedel M., van der Beek E.J., van Dokkum W., Kempen H.J., Kluft C., et al. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism 1987, 36:538-543.
26. Playford R.J., Wright N.A. Why is epidermal growth factor present in the gut lumen?. Gut 1996, 38:303-305.
27. Poulsen S.S., Nexø E., Olsen P.S., Hess J., Kirkegaard P. Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry 1986, 85:389-394.
28. Rüdiger H.A., Clavien P.A. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 2002, 122:202-210.
29. Sheth P., Seth A., Thangavel M., Basuroy S., Rao R.K. Epidermal growth factor prevents acetaldehyde-induced paracellular permeability in Caco-2 cell monolayer. Alcoholism: Clinical and Experimental Research 2004, 28:797-804.
30. Suzuki T., Seth A., Rao R. Role of phospholipase Cgamma-induced activation of protein kinase Cepsilon (PKCepsilon) and PKCbetaI in epidermal growth factor-mediated protection of tight junctions from acetaldehyde in Caco-2 cell monolayers. The Journal of Biological Chemistry 2008, 283:3574-3583.
31. Zandomeneghi R., Serra L., Baumgartl U., Poppi M.C. The role of epidermal growth factor in the pathogenesis of peptic ulcer disease. The American Journal of Gastroenterology 1991, 86:1150-1153.